Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Background The effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on kidney
failure, particularly the need for dialysis or transplantation or death due to kidney disease, is …

Background Renin–angiotensin system (RAS) inhibitors—including angiotensin-converting–
enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)—slow the progression …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Regular screening for the early detection of common chronic diseases might benefit from the
use of deep-learning approaches, particularly in resource-poor or remote settings. Here we …

Importance Chronic kidney disease (CKD) is the 16th leading cause of years of life lost
worldwide. Appropriate screening, diagnosis, and management by primary care clinicians …

The definition and classification of chronic kidney disease (CKD) have evolved over time,
but current international guidelines define this condition as decreased kidney function …

Importance Identifying patients at risk of chronic kidney disease (CKD) progression may
facilitate more optimal nephrology care. Kidney failure risk equations, including such factors …

Importance Using the same level of estimated glomerular filtration rate (eGFR) to define
chronic kidney disease (CKD) regardless of patient age may classify many elderly people …

Current criteria for the diagnosis of CKD in adults include persistent signs of kidney damage,
such as increased urine albumin-to-creatinine ratio or a GFR below the threshold of 60 …